BridgeMD
New treatment option for GATA2 Gene Mutation
Official title Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation
ClinicalTrials.gov ID: NCT05983991
What this study is testing
- What it's testing
- This trial is a translational, open-label, multi-site, retrospective and prospective cohort study of 250 patients aiming to characterize predictive parameters of clonal evolution in a population of subjects carrying the germline GATA2 mutation. This study will be conducted on a population of subjects either with previous germline GATA2 mutation identified or newly identified for germline GATA2 mutation in the context of routine care.
- Time commitment: about 5 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults. Healthy volunteers may be eligible.
You may be able to join if
- All subject, at any age, with a germline GATA2 mutation.
- Patient followed in the center within a standard of care procedure or clinical trial.
- Signed written informed consent. For minor patients: patient assent and legal guardian(s) written informed consent obtained before inclusion in the...
- For French patients: patient affiliated to a Social Health Insurance.
You likely can't join if
- GATA2 somatic mutation.
- Any psychological, familial, geographic or social situation, according to the judgment of investigator, potentially preventing the provision of...
- Person who has forfeited his/her freedom by administrative or legal award or who is under legal protection, with the exception of persons under...
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
- Bordeaux, France
- Clermont-Ferrand, France
- Dijon, France
- Grenoble, France
- Lille, France
- Lyon, France
- Marseille, France
- Montpellier, France
- Nantes, France
- Nice, France
- Paris, France
- Rennes, France
- Rouen, France
- Saint-Priest-en-Jarez, France
- Sèvres, France
- Strasbourg, France
- Toulouse, France
- Tours, France
- Vandœuvre-lès-Nancy, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 5 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France; Bordeaux, France; Clermont-Ferrand, France; Dijon, France; Grenoble, France; Lille, France and 14 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.